| Brand Name | Osinib |
| Packaging Type | Strip |
| Molecule | Osimertinib |
| Generic Name | Osimertinib 80mg |
| Manufactured By | Drug International Ltd. |
| Quantity | 30 Tablets |
| Form | Tablet |
| Country of Origin | Bangladesh |
| Categories | Oncology |
Introcution to Osinib 80mg Tablet
Osinib 80mg, Manufactured by Drug International Ltd. Osinib 80mg contains Osimertinib, a powerful third-generation EGFR tyrosine kinase inhibitor. This drug is specifically used to treat patients with non-small cell lung cancer (NSCLC) that carry mutations in the epidermal growth factor receptor (EGFR), including the T790M mutation, which often leads to immune to prior EGFR-targeted therapies.
Osinib Osimertinib 80mg works by blocking the abnormal activity of EGFR proteins that drive the uncontrolled growth of cancer cells, thereby helping to slow down or stop the progression of the cancer. It is commonly prescribed as a first-line treatment for metastatic NSCLC or for patients who have not responded to other EGFR inhibitors. Always follow the patient's doctor's instructions when taking Osinib 80mg to ensure safe and effective treatment.
Osimertinib 80 mg is used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Common side effects of Osimertinib include diarrhea, rash, dry skin, nail toxicity, and fatigue.
No, Tagrisso is not safe during pregnancy or breastfeeding. Use birth control while taking Tagrisso and for several weeks after your last dose.
Generic Tagrisso is not a cure for lung cancer, but it can significantly extend survival and delay disease progression in patients with advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
No, Tagrisso is neither chemotherapy nor immunotherapy. It is a targeted therapy specifically designed to inhibit mutated EGFR in certain types of lung cancer.
Generic Tagrisso works by inhibiting the activity of mutated EGFR, which is responsible for the growth of certain types of non-small cell lung cancer. By blocking this pathway, the drug prevents cancer cells from growing and spreading.
Yes, Tagrisso works by targeting and killing cancer cells that have specific EGFR mutations, inhibiting their growth and spread in non-small cell lung cancer (NSCLC).
If you miss a dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for the missed dose.
No, Osimertinib (Tagrisso) is a prescription medication, and you need a doctor’s prescription to obtain it.
You can order Osimertinib by logging into your account on our website, adding the tablet to your cart, and proceeding to checkout. After successful payment, your order will be confirmed, and you will receive a confirmation email. You can also contact us via WhatsApp to place your order directly.
